PPAR action in human placental development and pregnancy and its complications

PPAR Research

Volumn , Issue , 2008, Pages

  Wieser, Fritz ^a   Waite, Leslie ^a   Depoix, Christophe ^a   Taylor, Robert N ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLIMEPIRIDE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

CELL INVASION; CLINICAL TRIAL; DRUG ACTIVITY; DRUG TARGETING; HUMAN; NONHUMAN; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; REVIEW; TROPHOBLAST;

EID: 38649133784     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/527048     Document Type: Review

References (162)

1. G. Rizzo S. Fiorucci fiorucci@unipg.it PPARs and other nuclear receptors in inflammation. Current Opinion in Pharmacology 6 4 2006 421 427
2. A. Margeli G. Kouraklis S. Theocharis theocharis@ath.forthnet.gr Peroxisome proliferator activated receptor-γ (PPAR-γ) ligands and angiogenesis. Angiogenesis 6 3 2003 165 169
3. W. T. Schaiff Y. Barak Y. Sadovsky ysadovsky@wustl.edu The pleiotropic function of PPARγ in the placenta. Molecular and Cellular Endocrinology 249 1-2 2006 10 15
4. P. Froment froment@lyon.inserm.fr F. Gizard D. Defever B. Staels J. Dupont P. Monget Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. Journal of Endocrinology 189 2 2006 199 209
5. J. Berger D. E. Moller The mechanisms of action of PPARs. Annual Review of Medicine 53 2002 409 435
6. S. Kersten B. Desvergne W. Wahli walter.wahli@iba.unil.ch Roles of PPARs in health and disease. Nature 405 6785 2000 421 424
7. M. J. Holness G. K. Greenwood N. D. Smith M. C. Sugden m.c.sugden@qmul.ac.uk Peroxisome proliferator-activated receptor-α and glucocorticoids interactively regulate insulin secretion during pregnancy. Diabetes 55 12 2006 3501 3508
8. K. Nadra S. I. Anghel E. Joye Differentiation of trophoblast giant cells and their metabolic functions are dependent onperoxisome proliferator-activated receptor β/δ Molecular and Cellular Biology 26 8 2006 3266 3281
9. G. Krey A. Mahfoudi W. Wahli Functional interactions of peroxisome proliferator-activated receptor, retinoid-X receptor, and Sp1 inthe transcriptional regulation of the acyl- coenzyme-A oxidase promoter. Molecular Endocrinology 9 2 1995 219 231
10. Y. Guan Y. Zhang L. Davis M. D. Breyer Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. American Journal of Physiology - Renal Physiology 273 6 1997 F1013 F1022
11. T. Fournier V. Tsatsaris K. Handschuh D. Evain-Brion evain@pharmacie. univ-paris5.fr PPARs and the placenta. Placenta 28 2-3 2007 65 76
12. O. Braissant F. Foufelle C. Scotto M. Dauça W. Wahli Differential expression of peroxisome proliferator-activated receptors (PPARs):tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137 1 1996 354 366
13. L. Fajas J.-C. Fruchart J. Auwerx johan.auwerx@pasteur-lille.fr PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter. FEBS Letters 438 1-2 1998 55 60
14. P. Peraldi M. Xu B. M. Spiegelman bruce_spiegelman@dfci.harvard.edu Thiazolidinediones block tumor necrosis factor-α-induced inhibition of insulin signaling. Journal of Clinical Investigation 100 7 1997 1863 1869
15. Y. Barak M. C. Nelson E. S. Ong PPARγ is required for placental, cardiac, and adipose tissue development. Molecular Cell 4 4 1999 585 595
16. X. Zhang zhangxia@mail.ncifcrf.gov H. A. Young PPAR and immune system - what do we know? International Immunopharmacology 2 8 2002 1029 1044
17. E. Lord B. D. Murphy J. A. Desmarais S. Ledoux D. Beaudry M.-F. Palin palinmf@agr.gc.ca Modulation of peroxisome proliferator-activated receptor δ and γ transcripts in swineendometrial tissue during early gestation. Reproduction 131 5 2006 929 942
18. H. Higashiyama A. N. Billin Y. Okamoto M. Kinoshita S. Asano satoshi.asano@gsk.com Expression profiling of Peroxisome proliferator-activated receptor-δ (PPAR-δ) in mouse tissuesusing tissue microarray. Histochemistry and Cell Biology 127 5 2007 485 494
19. A. Chawla Y. Barak L. Nagy D. Liao P. Tontonoz R. M. Evans PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Medicine 7 1 2001 48 52
20. D. K. Krämer L. Al-Khalili B. Guigas Y. Leng P. M. Garcia-Roves A. Krook Anna.Krook@ki.se Role of AMP kinase and PPARδ in the regulation of lipid and glucose metabolism in human skeletal muscle. Journal of Biological Chemistry 282 27 2007 19313 19320
21. M. Adjuik. A. Babiker P. Garner P. Olliaro W. Taylor N. White Artesunate combinations for treatment of malaria: meta-analysis. The Lancet 363 9402 2004 9 17
22. K. S. Park T. P. Ciaraldi L. Abrams-Carter S. Mudaliar S. E. Nikoulina R. R. Henry rrhenry@vapop.ucsd.edu PPAR-γ gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes 46 7 1997 1230 1234
23. P. Imbeault H. Vidal A. Tremblay Age-related differences in messenger ribonucleic acid expression of key proteinsinvolved in adipose cell differentiation and metabolism. Journal of Clinical Endocrinology & Metabolism 86 2 2001 828 833
24. M. Iemitsu T. Miyauchi S. Maeda Aging-induced decrease in the PPAR-α level in hearts is improved by exercise training. American Journal of Physiology - Heart and Circulatory Physiology 283 5 2002 H1750 H1760
25. Q. N. Diep E. L. Schiffrin Increased expression of peroxisome proliferator-activated receptor-α and -γ in blood vessels ofspontaneously hypertensive rats. Hypertension 38 2 2001 249 254
26. O. Mezei W. J. Banz R. W. Steger M. R. Peluso T. A. Winters N. Shay Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese zucker rats and murine RAW 264.7 cells. Journal of Nutrition 133 2003 5 1238 1243
27. A. Vidal-Puig M. Jimenez-Lĩan B. B. Lowell Regulation of PPAR γ gene expression by nutrition and obesity in rodents. Journal of Clinical Investigation 97 1996 11 2553 2561
28. B. Delage C. Bairras B. Buaud V. Pallet P. Cassand A high-fat diet generates alterations in nuclear receptor expression: prevention by vitamin A and links with cyclooxygenase-2 and β-catenin. International Journal of Cancer 116 2005 6 839 846
29. J. P. Bastard B. Hainque E. Dusserre Peroxisome proliferator activated receptor-γ, leptin and tumor necrosis factor-α mRNA expression during very low calorie diet in subcutaneous adipose tissue in obese women. Diabetes/Metabolism Research and Reviews 15 1999 2 92 98
30. A. Petridou S. Tsalouhidou G. Tsalis T. Schulz H. Michna V. Mougios Long-term exercise increases the DNA binding activity of peroxisome proliferator-activated receptor γ in rat adipose tissue. Metabolism 56 2007 8 1029 1036
31. T. Fritz D. K. Krämer H. K. Karlsson Low-intensity exercise increases skeletal muscle protein expression of PPARδ and UCP3 in type 2 diabetic patients. Diabetes/Metabolism Research and Reviews 22 2006 6 492 498
32. A. J. Vidal-Puig R. V. Considine M. Jimenez-Lĩan Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. Journal of Clinical Investigation 99 1997 10 2416 2422
33. D. B. Savage G. D. Tan C. L. Acerini Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-γ Diabetes 52 2003 4 910 917
34. S. Y. Ding Z. F. Shen Y. T. Chen S. J. Sun Q. Liu M. Z. Xie Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats. Acta Pharmacologica Sinica 26 2005 5 575 580
35. R. Jaziri S. Lobbens R. Aubert The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism. Diabetes 55 2006 4 1157 1162
36. I. Ostlund B. Haglund U. Hanson Gestational diabetes and preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 113 2004 1 12 16
37. I. Delbaere Ilse.Delbaere@UGent.be H. Verstraelen S. Goetgeluk G. Martens G. De Backer M. Temmerman Pregnancy outcome in primiparae of advanced maternal age. European Journal of Obstetrics Gynecology & Reproductive Biology 135 1 2007 41 46
38. A. O. Odibo D. Nelson D. M. Stamilio H. M. Sehdev G. A. Macones Advanced maternal age is an independent risk factor for intrauterine growth restriction. American Journal of Perinatology 23 2006 5 325 328
39. B. M. Sibai M. Ewell R. J. Levine Risk factors associated with preeclampsia in healthy nulliparous women. The calcium for preeclampsia prevention (CPEP) study group. American Journal of Obstetrics & Gynecology 177 1997 5 1003 1010
40. R. Artal R. B. Catanzaro J. A. Gavard D. J. Mostello J. C. Friganza A lifestyle intervention of weight-gain restriction: diet and exercise in obese women with gestational diabetes mellitus. Applied Physiology, Nutrition, and Metabolism 32 2007 3 596 601
41. A. F. Saftlas N. Logsden-Sackett W. Wang R. Woolson M. B. Bracken Work, leisure-time physical activity, and risk of preeclampsia and gestational hypertension. American Journal of Epidemiology 160 2004 8 758 765
42. T. O. Scholl M. Leskiw X. Chen M. Sims T. P. Stein Oxidative stress, diet, and the etiology of preeclampsia. American Journal of Clinical Nutrition 81 2005 6 1390 1396
43. C. Zhang C. G. Solomon J. E. Manson F. B. Hu A prospective study of pregravid physical activity and sedentary behaviors in relation to the risk for gestational diabetes mellitus. Archives of Internal Medicine 166 2006 5 543 548
44. T. K. Sorensen M. A. Williams I. M. Lee E. E. Dashow M. L. Thompson D. A. Luthy Recreational physical activity during pregnancy and risk of preeclampsia. Hypertension 41 2003 6 1273 1280
45. M. I. Cedergren Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstetrics & Gynecology 103 2004 2 219 224
46. T. E. O'Brien J. G. Ray W. S. Chan Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 14 2003 3 368 374
47. H. S. Ros S. Cnattingius L. Lipworth Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. American Journal of Epidemiology 147 1998 11 1062 1070
48. N. J. Sebire M. Jolly J. P. Harris Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London. International Journal of Obesity and Related Metabolic Disorders 25 2001 8 1175 1182
49. L. M. Bodnar J. M. Catov M. A. Klebanoff R. B. Ness J. M. Roberts Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 18 2007 2 234 239
50. J. G. Ray M. J. Vermeulen M. J. Schull S. McDonald D. A. Redelmeier Metabolic syndrome and the risk of placental dysfunction. Journal of Obstetrics and Gynaecology Canada 27 2005 12 1095 1101
51. M. Wolf L. Sandler K. Mũoz K. Hsu J. L. Ecker R. Thadhani First trimester insulin resistance and subsequent preeclampsia: a prospective study. Journal of Clinical Endocrinology & Metabolism 87 2002 4 1563 1568
52. L. M. Bodnar bodnar@edc.pitt.edu G. Tang R. B. Ness G. Harger J. M. Roberts Periconceptional multivitamin use reduces the risk of preeclampsia. American Journal of Epidemiology 164 5 2006 470 477
53. C. Zhang M. B. Schulze C. G. Solomon F. B. Hu A prospective study of dietary patterns, meat intake and the risk of gestational diabetes mellitus. Diabetologia 49 2006 11 2604 1613
54. S. C. Kalhan sck@po.cwru.edu Protein metabolism in pregnancy. American Journal of Clinical Nutrition 71 5, supplement 2000 1249S 1255S
55. E. Sivan G. Boden bodengh@tuhs.temple.edu Free fatty acids, insulin resistance, and pregnancy. Current Diabetes Reports 3 4 2003 319 322
56. J. M. Potter P. J. Nestel The hyperlipidemia of pregnancy in normal and complicated pregnancies. American Journal of Obstetrics & Gynecology 133 2 1979 165 170
57. J. Bonnar L. Daly B. L. Sheppard Changes in the fibrinolytic system during pregnancy. Seminars in Thrombosis and Hemostasis 16 3 1990 221 229
58. D. M. Sherer O. Abulafia Angiogenesis during implantation, and placental and early embryonic development. Placenta 22 1 2001 1 13
59. A. Yessoufou A. Hichami P. Besnard K. Moutairou N. A. Khan Naim.Khan@u-bourgogne.fr Peroxisome proliferator-activated receptor α deficiency increases the risk of maternalabortion and neonatal mortality in murine pregnancy with or without diabetes mellitus: modulation of T cell differentiation. Endocrinology 147 9 2006 4410 4418
60. Y. Barak D. Liao W. He Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 99 1 2002 303 308
61. N. Kubota Y. Terauchi H. Miki PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Molecular Cell 4 4 1999 597 609
62. Y.-J. Zhu S. E. Crawford V. Stellmach Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulatorof placental, cardiac, hepatic, and embryonic development. Journal of Biological Chemistry 278 3 2003 1986 1990
63. P. Antonson per.antonsonr@cbt.ki.se G. U. Schuster L. Wang Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction. Molecular and Cellular Biology 23 4 2003 1260 1268
64. V. Sapin Vincent.SAPIN@inserm.u-clermont1.fr P. Dollé C. Hindelang P. Kastner P. Chambon igbmc@igbmc.u-strasbg.fr Defects of the chorioallantoic placenta in mouse RXRα null fetuses. Developmental Biology 191 1 1997 29 41
65. B. Sibai baha.sibai@uc.edu G. Dekker M. Kupferminc Pre-eclampsia. The Lancet 365 9461 2005 785 799
66. J. M. Roberts C. W. G. Redman Pre-eclampsia: more than pregnancy-induced hypertension. The Lancet 341 8858 1993 1447 1451
67. G. T. R. Manten wmanten@veldhuizen.speedxs.nl M. J. Sikkema H. A. M. Voorbij G. H. A. Visser H. W. Bruinse A. Franx Risk factors for cardiovascular disease in women with a history of pregnancy complicatedby preeclampsia or intrauterine growth restriction. Hypertension in Pregnancy 26 1 2007 39 50
68. V. A. Rodie vanessarodie@hotmail.com D. J. Freeman N. Sattar I. A. Greer Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 175 2 2004 189 202
69. J. Newstead jill.newstead@shaw.ca P. von Dadelszen pvd@cw.bc.ca L. A. Magee lmagee@cw.bc.ca Preeclampsia and future cardiovascular risk. Expert Review of Cardiovascular Therapy 5 2 2007 283 294
70. R. J. Kaaja risto.kaaja@hus.fi I. A. Greer Manifestations of chronic disease during pregnancy. Journal of the American Medical Association 294 21 2005 2751 2757
71. I. A. Brosens ivo.brosens@med.kuleuven.ac.be P. De Sutter T. Hamerlynck Endometriosis is associated with a decreased risk of pre-eclampsia. Human Reproduction 22 6 2007 1725 1729
72. F. Xue K. B. Michels Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncology 8 12 2007 1088 1100
73. J. Vamecq lvallee@chru-lille.fr N. Latruffe Medical significance of peroxisome proliferator-activated receptors. The Lancet 354 9173 1999 141 148
74. J. M. Lehmann L. B. Moore T. A. Smith-Oliver W. O. Wilkison T. M. Willson S. A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). Journal of Biological Chemistry 270 22 1995 12953 12956
75. H. Vosper G. A. Khoudoli T. L. Graham C. N. Palmer palmerc@icrf.icnet.uk Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis. Pharmacology & Therapeutics 95 1 2002 47 62
76. C. Chambrier J.-P. Bastard J. Rieusset Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor γ Obesity Research 10 6 2002 518 525
77. S. A. Kliewer J. M. Lenhard T. M. Willson I. Patel D. C. Morris J. M. Lehmann A prostaglandin J 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83 5 1995 813 819
78. G. Chinetti J.-C. Fruchart B. Staels bart.staels@pasteur-lille.fr Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at thecrossroads between lipid metabolism and inflammation. Inflammation Research 49 10 2000 497 505
79. L. Waite E. C. Person Y. Zhou K.-H. Lim T. S. Scanlan R. N. Taylor Placental peroxisome proliferator-activated receptor-γ is up-regulated by pregnancy serum. Journal of Clinical Endocrinology & Metabolism 85 10 2000 3808 3814
80. Q. Wang H. Fujii G. T. Knipp gknipp@cop.rutgers.edu Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta 23 8-9 2002 661 671
81. A. Tarrade R. Lai Kuen A. Malassiné Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Laboratory Investigation 81 9 2001 1199 1211
82. T. Fournier t.fournier@pharmacie.univ-paris5.fr L. Pavan A. Tarrade The role of PPAR-γ/RXR-α heterodimers in the regulation of human trophoblast invasion. Annals of the New York Academy of Sciences 973 2002 26 30
83. A. Tarrade K. Schoonjans J. Guibourdenche PPARγ/RXRα heterodimers are involved in human CGβ synthesis and human trophoblast differentiation. Endocrinology 142 10 2001 4504 4514
84. R. L. Schild W. T. Schaiff M. G. Carlson E. J. Cronbach D. M. Nelson Y. Sadovsky sadovskyy@msnotes.wustl.edu The activity of PPARγ in primary human trophoblasts is enhanced by oxidized lipids. Journal of Clinical Endocrinology & Metabolism 87 3 2002 1105 1110
85. M. Lappas mlappas@unimelb.edu.au M. Permezel G. E. Rice Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from humanplacenta and maternal adipose tissue via nuclear factor-κB, peroxisomal proliferator-activated receptor-γ andextracellularly regulated kinase 1/2. Endocrinology 146 8 2005 3334 3342
86. W. T. Schaiff I. Bildirici M. Cheong P. L. Chern D. M. Nelson Y. Sadovsky ysadovsky@wustl.edu Peroxisome proliferator-activated receptor-γ and retinoid X receptor signaling regulate fatty aciduptake by primary human placental Trophoblasts. Journal of Clinical Endocrinology & Metabolism 90 7 2005 4267 4275
87. T. Shalom-Barak J. M. Nicholas Y. Wang Peroxisome proliferator-activated receptor γ controls Muc1 transcription in trophoblasts. Molecular and Cellular Biology 24 24 2004 10661 10669
88. R. Asami-Miyagishi S. Iseki M. Usui K. Uchida H. Kubo I. Morita morita.cell@tmd.ac.jp Expression and function of PPARγ in rat placental development. Biochemical and Biophysical Research Communications 315 2 2004 497 501
89. E. Capobianco A. Jawerbaum a.jawerbaum@abaconet.com.ar M. C. Romanini 15-deoxy-Δ12,14-prostaglandin J 2 and peroxisome proliferator-activated receptor γ (PPARγ) levels in term placentaltissues from control and diabetic rats: modulatory effects of a PPARγ agonist on nitridergic and lipid placental metabolism. Reproduction, Fertility and Development 17 4 2005 423 433
90. M. Lappas mlappas@unimelb.edu.au M. Permezel H. M. Georgiou G. E. Rice Regulation of proinflammatory cytokines in human gestational tissues by peroxisomeproliferator-activated receptor-γ: effect of 15-deoxy-Δ12,14- PGJ 2 and troglitazone. Journal of Clinical Endocrinology & Metabolism 87 10 2002 4667 4672
91. K. W. Marvin k.marvin@auckland.ac.nz R. L. Eykholt J. A. Keelan T. A. Sato M. D. Mitchell The 15-deoxy-Δ12,14-prostaglandin J 2 receptor, peroxisome proliferator activated receptor-γ (PPARγ) is expressedin human gestational tissues and is functionally active in JEG3 choriocarcinoma cells. Placenta 21 4 2000 436 440
92. L. R. Dunn-Albanese W. E. Ackerman IV Y. Xie J. D. Iams D. A. Kniss kniss.l@osu.edu Reciprocal expression of peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in human term parturition. American Journal of Obstetrics & Gynecology 190 3 2004 809 816
93. E. B. E. Berry ebe.berry@auckland.ac.nz R. Eykholt R. J. A. Helliwell R. S. Gilmour M. D. Mitchell K. W. Marvin Peroxisome proliferator-activated receptor isoform expression changes in humangestational tissues with labor at term. Molecular Pharmacology 64 6 2003 1586 1590
94. O. Wendling P. Chambon M. Mark Retinoid X receptors are essential for early mouse development and placentogenesis. Proceedings of the National Academy of Sciences of the United States of America 96 1999 2 547 551
95. L. L. H. Peeters l.peeters@og.unimaas.nl J.-L. Vigne M. K. Tee D. Zhao L. Waite R. N. Taylor PPARγ represses VEGF expression in human endometrial cells: implications for uterine angiogenesis. Angiogenesis 8 4 2006 373 379
96. H. Bamba bam@saitama-med.ac.jp S. Ota A. Kato C. Kawamoto K. Fujiwara Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiatedU937 cells. Biochemical and Biophysical Research Communications 273 2 2000 485 491
97. V. Chintalgattu G. S. Harris S. M. Akula L. C. Katwa KatwaL@ecu.edu PPAR-γ agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. Cardiovascular Research 74 1 2007 140 150
98. K. Yamakawa M. Hosoi my-hosoi@yb3.so-net.ne.jp H. Koyama Peroxisome proliferator-activated receptor-γ agonists increase vascular endothelial growth factorexpression in human vascular smooth muscle cells. Biochemical and Biophysical Research Communications 271 3 2000 571 574
99. K. Handschuh J. Guibourdenche M. Guesnon I. Laurendeau D. Evain-Brion T. Fournier Thierry.Fournier@univ-paris5.fr Modulation of PAPP-A expression by PPARγ in human first trimester trophoblast. Placenta 27, supplement 1 2006 127 134
100. B. M. Forman P. Tontonoz J. Chen R. P. Brun B. M. Spiegelman R. M. Evans 15-deoxy-Δ12,14-prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ Cell 83 5 1995 803 812
101. R. L. Schild C. M. Sonnenberg-Hirche W. T. Schaiff I. Bildirici D. M. Nelson Y. Sadovsky ysadovsky@wustl.edu The kinase p38 regulates peroxisome proliferator activated receptor- in human trophoblasts. Placenta 27 2-3 2006 191 199
102. S. S.-T. Lee F. J. Gonzalez Targeted disruption of the peroxisome proliferator-activated receptor α gene, PPARα Annals of the New York Academy of Sciences 804 1996 1 524 529
103. G. B. Dealtry M. K. O'Farrell N. Fernandez The Th2 cytokine environment of the placenta. International Archives of Allergy and Immunology 123 2 2000 107 119
104. J. C. Huang W. S. Wun J. S. Goldsby I. C. Wun D. Noorhasan K. K. Wu Stimulation of embryo hatching and implantation by prostacyclin and peroxisome proliferator-activatedreceptor δ activation: implication in IVF. Human Reproduction 22 3 2007 807 814
105. H. Lim S. K. Dey SDEY@kumc.edu PPARδ functions as a prostacyclin receptor in blastocyst implantation. Trends in Endocrinology & Metabolism 11 4 2000 137 142
106. M. Lappas M. Permezel H. M. Georgiou G. E. Rice Nuclear factor κ B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biology of Reproduction 67 2 2002 668 673
107. S. A. Törnblom susanne.abelin@kbh.ki.se F. A. Patel B. Byström 15-Hydroxyprostaglandin dehydrogenase and cyclooxygenase 2 messenger ribonucleic acid expressionand immunohistochemical localization in human cervical tissue during term and preterm labor. Journal of Clinical Endocrinology & Metabolism 89 6 2004 2909 2915
108. M. Lappas mlappas@unimelb.edu.au M. Permezel G. E. Rice 15-deoxy-Δ12,14-rostaglandin J 2 and troglitazone regulation of the release of phospholipid metabolites,inflammatory cytokines and proteases from guman gestational tissues. Placenta 27 11-12 2006 1060 1072
109. E. T. McKinney R. Shouri R. S. Hunt R. A. Ahokas B. M. Sibai Plasma, urinary, and salivary 8-epi-prostaglandin F 2α levels in normotensive and preeclamptic pregnancies. American Journal of Obstetrics & Gynecology 183 4 2000 874 877
110. D. B. Klinkner H. J. Lim E. Y. Strawn Jr. K. T. Oldham T. L. Sander sandert@mcw.edu An in vivo murine model of rosiglitazone use in pregnancy. Fertility and Sterility 86 4, supplement 1 2006 1074 1079
111. L. Waite lwaite@itsa.ucsf.edu R. E. Louie R. N. Taylor Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy. Journal of Clinical Endocrinology & Metabolism 90 2 2005 620 626
112. E. C. Tok tokekrem@hotmail.com D. Ertunc O. Bilgin E. M. Erdal M. Kaplanoglu S. Dilek PPAR-γ2 Pro12Ala polymorphism is associated with weight gain in women with gestational diabetes mellitus. European Journal of Obstetrics Gynecology & Reproductive Biology 129 1 2006 25 30
113. A. Jawerbaum E. Capobianco C. Pustovrh Influence of peroxisome proliferator-activated receptor γ activation by its endogenous ligand15-deoxyΔ12,14 prostaglandin J 2 on nitric oxide production in term placental tissues from diabetic women. Molecular Human Reproduction 10 9 2004 671 676
114. L. Capparuccia lorenag23@libero.it D. Marzioni A. Giordano PPARγ expression in normal human placenta, hydatidiform mole and choriocarcinoma. Molecular Human Reproduction 8 6 2002 574 579
115. V. A. Rodie vanessarodie@hotmail.com A. Young F. Jordan N. Sattar I. A. Greer D. J. Freeman Human placental peroxisome proliferator-activated receptor δ and γ expression in healthy pregnancyand in preeclampsia and intrauterine growth restriction. Journal of the Society for Gynecologic Investigation 12 5 2005 320 329
116. A. Meirhaeghe aline.meirhaeghe-hurez@pasteur-lille.fr C. A. G. Boreham L. J. Murray A possible role for the PPARG Pro12Ala polymorphism in preterm birth. Diabetes 56 2 2007 494 498
117. J. R. Higgins M. de Swiet mdeswiet@ic.ac.uk Blood-pressure measurement and classification in pregnancy. The Lancet 357 9250 2001 131 135
118. A. P. Mackay anm3@cdc.gov C. J. Berg H. K. Atrash Pregnancy-related mortality from preeclampsia and eclampsia. Obstetrics & Gynecology 97 4 2001 533 538
119. R. N. Taylor C. J. M. de Groot Y. K. Cho K.-H. Lim Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Seminars in Reproductive Endocrinology 16 1 1998 17 31
120. Y. Hamai T. Fujii T. Yamashita Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-α levels before the clinicalmanifestations of preeclampsia. American Journal of Reproductive Immunology 38 2 1997 89 93
121. K.-A. Wathén E. Tuutti U.-H. Stenman Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending inpreeclampsia or intrauterine growth retardation. Journal of Clinical Endocrinology & Metabolism 91 1 2006 180 184
122. S.-M. Yie L.-H. Li Y.-M. Li C. Librach cliffl@ican.net HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. American Journal of Obstetrics & Gynecology 191 2 2004 525 529
123. R. Thadhani thadhani.r@mgh.harvard.edu W. P. Mutter M. Wolf First trimester placental growth factor and soluble FMS-like tyrosine kinase 1 and risk for preeclampsia. Journal of Clinical Endocrinology & Metabolism 89 2 2004 770 775
124. D. V. Coonrod D. E. Hickok K. Zu T. R. Easterling J. R. Daling Risk factors for preeclampsia in twin pregnancies: a population-based cohort study. Obstetrics & Gynecology 85 5, part 1 1995 645 650
125. M. J. McMahon C. V. Ananth R. M. Liston Gestational diabetes mellitus: risk factors, obstetric complications and infant outcomes. Journal of Reproductive Medicine for the Obstetrician and Gynecologist 43 4 1998 372 378
126. M. Tanaka G. Jaamaa M. Kaiser Racial disparity in hypertensive disorders of pregnancy in New York state: a 10-year longitudinal population-based study. American Journal of Public Health 97 1 2007 163 170
127. B. A. Beamer C.-J. Yen R. E. Andersen Association of the Pro12Ala variant in the peroxisome proliferator- activated receptor-γ2 gene with obesity intwo Caucasian populations. Diabetes 47 11 1998 1806 1808
128. S. J. Hasstedt Q.-F. Ren K. Teng S. C. Elbein elbeinstevenc@exchange. uams.edu Effect of the peroxisome proliferator-activated receptor-γ2 Pro12Ala variant on obesity, glucosehomeostasis, and blood pressure in members of familial type 2 diabetic kindreds. Journal of Clinical Endocrinology & Metabolism 86 2 2001 536 541
129. W.-D. Li J. H. Lee R. A. Price The peroxisome proliferator-activated receptor γ2 Pro12Ala mutation is associated with early onset extremeobesity and reduced fasting glucose. Molecular Genetics and Metabolism 70 2 2000 159 161
130. S. S. Deeb deeb@genetics.washington.edu L. Fajas M. Nemoto A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass indexand improved insulin sensitivity. Nature Genetics 20 3 1998 284 287
131. J. Laasanen S. Heinonen M. Hiltunen A. Mannermaa M. Laakso Polymorphism in the peroxisome proliferator-activated receptor-γ gene in women with preeclampsia. Early Human Development 69 1-2 2002 77 82
132. C. A. Hubel hubelc+@pitt.edu Oxidative stress in the pathogenesis of preeclampsia. Proceedings of the Society for Experimental Biology and Medicine 222 3 1999 222 235
133. B. W. Arbogast S. C. Leeper R. D. Merrick K. E. Olive R. N. Taylor Which plasma factors bring about disturbance of endothelial function in pre-eclampsia? The Lancet 343 8893 1994 340 341
134. C. W. G. Redman christopher.redman@obsgyn.oxford.ac.uk I. L. Sargent Pre-eclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta 24, supplement 1 2003 S21 S27
135. M. J. Reginato S. L. Krakow S. T. Bailey M. A. Lazar lazar@mail.med. upenn.edu Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ Journal of Biological Chemistry 273 4 1998 1855 1858
136. P. L. Ogburn Jr. S. B. Johnson P. P. Williams R. T. Holman Levels of free fatty acids and arachidonic acid in pregnancy and labor. Journal of Laboratory and Clinical Medicine 95 6 1980 943 949
137. P. L. Ogburn Jr. P. P. Williams S. B. Johnson R. T. Holman Serum arachidonic acid levels in normal and preeclamptic pregnancies. American Journal of Obstetrics & Gynecology 148 1 1984 5 9
138. C. J. M. de Groot J. T. Murai J.-L. Vigne R. N. Taylor Eicosanoid secretion by human endothelial cells exposed to normal pregnancy and preeclampsia plasma in vitro. Prostaglandins Leukotrienes and Essential Fatty Acids 58 2 1998 91 97
139. D. Hornung I. P. Ryan V. A. Chao J.-L. Vigne E. D. Schriock R. N. Taylor Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. Journal of Clinical Endocrinology & Metabolism 82 5 1997 1621 1628
140. S. Blackburn D. Loper Maternal Fetal and Neonatal Physiology: A Clinical Perspective. Harcourt Brace Jovanovic Philadelphia, Pa, USA 1992
141. W. W. Hay Jr. Placental transport of nutrients to the fetus. Hormone Research 42 4-5 1994 215 222
142. L. Jovanovic D. J. Pettitt Gestational diabetes mellitus. Journal of the American Medical Association 286 20 2001 2516 2518
143. C. B. Rudra clb3@u.washington.edu T. K. Sorensen W. M. Leisenring E. Dashow M. A. Williams Weight characteristics and height in relation to risk of gestational diabetes mellitus. American Journal of Epidemiology 165 3 2007 302 308
144. F. Galtier-Dereure ofdereure@wanadoo.fr C. Boegner J. Bringer Obesity and pregnancy: complications and cost. American Journal of Clinical Nutrition 71 5, supplement 2000 1242S 1248S
145. P. M. Catalano Increasing maternal obesity and weight gain during pregnancy: the obstetric problems of plentitude. Obstetrics & Gynecology 110 4 2007 743 744
146. C. J. P. Jones H. Fox Placental changes in gestational diabetes. An ultrastructural study. Obstetrics & Gynecology 48 3 1976 274 280
147. A. Åberg H. Rydhstroem A. Frid Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based studyin southern Sweden. American Journal of Obstetrics & Gynecology 184 2 2001 77 83
148. D. B. Carr darcarr@u.washington.edu K. M. Utzschneider R. L. Hull Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family historyof type 2 diabetes. Diabetes Care 29 9 2006 2078 2083
149. H. Lee H. C. Jang H. K. Park N. H. Cho chnaha@ajou.ac.kr Early manifestation of cardiovascular disease risk factors in offspring of mothers with previous history ofgestational diabetes mellitus. Diabetes Research and Clinical Practice 78 2 2007 238 245
150. M. Morifuji C. Sanbongi K. Sugiura Dietary soya protein intake and exercise training have an additive effect on skeletal muscle fatty acidoxidation enzyme activities and mRNA levels in rats. British Journal of Nutrition 96 3 2006 469 475
151. C. Zhang cuilin.zhang@channing.harvard.edu S. Liu C. G. Solomon F. B. Hu frank.hu@channing.harvard.edu Dietary fiber intake, dietary glycemic load, and the risk for gestational diabetes mellitus. Diabetes Care 29 10 2006 2223 2230
152. E. Oken emily_oken@hphc.org Y. Ning S. L. Rifas-Shiman J. S. Radesky J. W. Rich-Edwards M. W. Gillman Associations of physical activity and inactivity before and during pregnancy with glucose tolerance. Obstetrics & Gynecology 108 5 2006 1200 1207
153. T. L. Weissgerber L. A. Wolfe G. A. L. Davies M. F. Mottola mmottola@uwo.ca Exercise in the prevention and treatment of maternal-fetal disease: a review of the literature. Applied Physiology, Nutrition and Metabolism 31 6 2006 661 674
154. H. Leipold M. Knoefler C. Gruber A. Huber P. Haslinger C. Worda christof.worda@meduniwien.ac.at Peroxisome proliferator-activated receptor γ coactivator-1α gene variations are not associated withgestational diabetes mellitus. Journal of the Society for Gynecologic Investigation 13 2 2006 104 107
155. S. Fukuen M. Iwaki A. Yasui M. Makishima M. Matsuda mmatsuda@fbs.osaka-u. ac.jp I. Shimomura ichi@imed2.med.osaka-u.ac.jp Sulfonylurea agents exhibit peroxisome proliferator-activated receptor γ agonistic activity. Journal of Biological Chemistry 280 25 2005 23653 23659
156. O. Langer olanger@slrhc.org. D. L. Conway M. D. Berkus E. M.-J. Xenakis O. Gonzales A comparison of glyburide and insulin in women with gestational diabetes mellitus. New England Journal of Medicine 343 16 2000 1134 1138
157. C. Ferretti L. Bruni V. Dangles-Marie A. P. Pecking D. Bellet dominique.bellet@univ-paris5.fr Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasiveand migratory capacities of trophoblasts. Human Reproduction Update 13 2 2007 121 141
158. D. P. Hewitt P. J. Mark B. J. Waddell bwaddell@anhb.uwa.edu.au Placental expression of peroxisome proliferator-activated receptors in rat pregnancy and theeffect of increased glucocorticoid exposure. Biology of Reproduction 74 1 2006 23 28
159. W. T. Schaiff F. F. Knapp Jr. Y. Barak T. Biron-Shental D. M. Nelson Y. Sadovsky ysadovsky@wustl.edu Ligand-activated peroxisome proliferator activated receptor γ alters placental morphology and placentalfatty acid uptake in mice. Endocrinology 148 8 2007 3625 3634
160. J. A. Keelan j.keelan@auckland.ac.nz R. J. A. Helliwell B. E. Nijmeijer 15-deoxy-Δ12,14-prostaglandin J 2-induced apoptosis in amnion-like WISH cells. Prostaglandins & Other Lipid Mediators 66 4 2001 265 282
161. H. Hasegawa H. Takano Y. Zou Pioglitazone, a peroxisome proliferator-activated receptor γ activator, ameliorates experimentalautoimmune myocarditis by modulating Th1/Th2 balance. Journal of Molecular and Cellular Cardiology 38 2 2005 257 265
162. S. Dasgupta A. Roy M. Jana D. M. Hartley K. Pahan kalipada_pahan@rush.edu Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitisindependent of peroxisome proliferator-activated receptor-α Molecular Pharmacology 72 4 2007 934 946